Brinny, Republic of Ireland
MSD (Merck Sharp Dohme) opened the Bioassay Centre of Expertise and the Pneumococcal Vaccine Conjugation Facility in June of 2011 in Brinny, Ireland. The facilities represent an investment of $41 million and will support the development, commercialization, and manufacture of vaccines and protein-based therapeutics.
